1 New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity Oct 27, 2024
5 Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved! Jul 05, 2023
6 New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu Jul 04, 2023
Read More Medical Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug May 23, 2025
